Drug
Fluticasone Propionate
Fluticasone Propionate: highest development phase Approved, developed by Hikma, Pfizer, Teva. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Hikma, Pfizer, Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| FLUTICASONE PROPIONATE AND SALMETEROL | Approved | |
| FLUTICASONE PROPIONATE AND SALMETEROL | Approved | |
| Fluticasone Propionate NCT01364519 | Phase 1 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow Fluticasone Propionate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.